Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $829.71 billion, total revenue of $166.46 billion and a weighted average PE ratio of 53.71.
Market Cap
829.71B
Revenue
166.46B
Profits
15.45B
PE Ratio
53.71
Profit Margin
9.28%
Dividend Yield
0.19%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 235.90B | 0.20% | 122,357 | 43.74B |
| 2 | DHR | Danaher Corporation | 167.00B | -0.12% | 724,829 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 55.82B | 0.18% | 39,717 | 4.17B |
| 4 | IQV | IQVIA Holdings Inc. | 40.73B | -0.10% | 115,571 | 15.90B |
| 5 | A | Agilent Technologies, Inc. | 38.62B | 0.42% | 13,169 | 6.95B |
| 6 | NTRA | Natera, Inc. | 33.20B | -0.58% | 54,283 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 29.29B | 0.56% | 4,915 | 3.94B |
| 8 | ILMN | Illumina, Inc. | 23.41B | 0.12% | 54,329 | 4.29B |
| 9 | WAT | Waters Corporation | 23.25B | -0.09% | 36,878 | 3.11B |
| 10 | LH | Labcorp Holdings Inc. | 22.26B | 0.43% | 24,346 | 13.77B |
| 11 | DGX | Quest Diagnostics Incorporated | 20.37B | 0.31% | 41,225 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.44B | -0.07% | 141,523 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.04B | 0.48% | 4,538 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 14.91B | 0.83% | 81,981 | 902.57M |
| 15 | ICLR | ICON Public Limited Company | 14.44B | 0.86% | 3,538 | 8.10B |
| 16 | RVTY | Revvity, Inc. | 13.04B | 0.25% | 64,271 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 11.27B | 0.87% | 132,449 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 10.97B | 0.20% | 12,507 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.70B | -0.38% | 9,285 | 1.97B |
| 20 | SHC | Sotera Health Company | 5.30B | 0.32% | 35,384 | 1.15B |
| 21 | GRAL | GRAIL, Inc. | 4.03B | -2.65% | 54,512 | 141.83M |
| 22 | BLLN | BillionToOne, Inc. | 4.00B | 1.31% | 87 | 254.14M |
| 23 | VCYT | Veracyte, Inc. | 3.15B | -1.63% | 27,212 | 495.14M |
| 24 | WGS | GeneDx Holdings Corp. | 2.95B | -2.75% | 30,190 | 402.19M |
| 25 | TWST | Twist Bioscience Corporation | 2.59B | -0.38% | 61,434 | 376.57M |
| 26 | NEOG | Neogen Corporation | 2.20B | 1.00% | 127,467 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.58B | -1.69% | 53,531 | 709.16M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.26B | 0.23% | 18,628 | 343.53M |
| 29 | CDNA | CareDx, Inc. | 1.06B | -0.84% | 32,534 | 358.00M |
| 30 | OPK | OPKO Health, Inc. | 994.17M | -0.38% | 52,085 | 642.07M |
| 31 | PSNL | Personalis, Inc. | 913.80M | -0.68% | 129,442 | 69.10M |
| 32 | FLGT | Fulgent Genetics, Inc. | 847.93M | -0.36% | 6,239 | 315.55M |
| 33 | MYGN | Myriad Genetics, Inc. | 529.45M | -2.24% | 21,112 | 825.30M |
| 34 | BNR | Burning Rock Biotech Limited | 381.03M | - | 9 | 75.75M |
| 35 | PRE | Prenetics Global Limited | 313.85M | 1.63% | 40,126 | 77.08M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 187.90M | -0.23% | 3,374 | 4.40M |
| 37 | MDXH | MDxHealth SA | 185.12M | 0.81% | 610 | 103.07M |
| 38 | FONR | FONAR Corporation | 122.18M | 0.11% | 235 | 105.43M |
| 39 | XGN | Exagen Inc. | 99.60M | -0.34% | 29,408 | 63.60M |
| 40 | BDSX | Biodesix, Inc. | 83.93M | 4.56% | 33,217 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 43.78M | -0.04% | - | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 17.95M | -1.15% | 14,168 | 513.02M |
| 43 | MBAI | Check-Cap Ltd. | 14.99M | -22.47% | 1,575,241 | - |
| 44 | MYNZ | Mainz Biomed N.V. | 11.78M | - | 24,585 | 659.94K |
| 45 | ADVB | Advanced Biomed Inc. | 6.94M | 3.72% | 564 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 5.93M | 1.54% | 2,664 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 5.20M | 1.59% | 298 | - |
| 48 | ISPC | iSpecimen Inc. | 3.46M | -5.77% | 17,545 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 1.86M | -3.97% | 20,908 | 29.52M |